Secondly, CAD patients showed a significant reduction in serum TC, LDL-C, Apo-A1, Apo-B and GSP levels; however, there were no significant changes in SREBP-2 mRNA expression. This evidence concerns the gene SREBF2 and coronary artery disorder.